全文获取类型
收费全文 | 33561篇 |
免费 | 1965篇 |
国内免费 | 269篇 |
专业分类
耳鼻咽喉 | 445篇 |
儿科学 | 602篇 |
妇产科学 | 496篇 |
基础医学 | 4158篇 |
口腔科学 | 1553篇 |
临床医学 | 2744篇 |
内科学 | 9012篇 |
皮肤病学 | 394篇 |
神经病学 | 3367篇 |
特种医学 | 1312篇 |
外科学 | 5323篇 |
综合类 | 93篇 |
一般理论 | 6篇 |
预防医学 | 1407篇 |
眼科学 | 546篇 |
药学 | 1736篇 |
中国医学 | 73篇 |
肿瘤学 | 2528篇 |
出版年
2024年 | 32篇 |
2023年 | 360篇 |
2022年 | 671篇 |
2021年 | 1260篇 |
2020年 | 754篇 |
2019年 | 1023篇 |
2018年 | 1213篇 |
2017年 | 959篇 |
2016年 | 1072篇 |
2015年 | 1134篇 |
2014年 | 1466篇 |
2013年 | 1789篇 |
2012年 | 2790篇 |
2011年 | 2689篇 |
2010年 | 1509篇 |
2009年 | 1366篇 |
2008年 | 2153篇 |
2007年 | 2274篇 |
2006年 | 2038篇 |
2005年 | 1852篇 |
2004年 | 1651篇 |
2003年 | 1516篇 |
2002年 | 1313篇 |
2001年 | 282篇 |
2000年 | 245篇 |
1999年 | 251篇 |
1998年 | 246篇 |
1997年 | 205篇 |
1996年 | 156篇 |
1995年 | 145篇 |
1994年 | 132篇 |
1993年 | 114篇 |
1992年 | 125篇 |
1991年 | 100篇 |
1990年 | 87篇 |
1989年 | 61篇 |
1988年 | 92篇 |
1987年 | 63篇 |
1986年 | 49篇 |
1985年 | 65篇 |
1984年 | 55篇 |
1983年 | 45篇 |
1982年 | 47篇 |
1981年 | 29篇 |
1980年 | 24篇 |
1979年 | 42篇 |
1978年 | 31篇 |
1977年 | 22篇 |
1973年 | 31篇 |
1972年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Pande Apurva Lamba Nayan Mammi Marco Gebrehiwet Paulos Trenary Alyssa Doucette Joanne Papatheodorou Stefania Bunevicius Adomas Smith Timothy R. Mekary Rania A. 《Neurosurgical review》2021,44(3):1227-1241
Neurosurgical Review - Treatment options for hydrocephalus include endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS). Some ambiguity remains regarding indications, safety,... 相似文献
92.
Anania Pasquale Battaglini Denise Balestrino Alberto DAndrea Alessandro Prior Alessandro Ceraudo Marco Rossi Diego Criminelli Zona Gianluigi Fiaschi Pietro 《Neurosurgical review》2021,44(3):1243-1253
Neurosurgical Review - Posterior cranial fossa tumours frequently develop hydrocephalus as first presentation in up to 80% of paediatric patients and 21.4% of adults, although it resolves after... 相似文献
93.
Ricciardi Luca Stifano Vito Pucci Resi Stumpo Vittorio Montano Nicola Della Monaca Marco Lauretti Liverana Olivi Alessandro Valentini Valentino Sturiale Carmelo Lucio 《Neurosurgical review》2021,44(1):153-161
Neurosurgical Review - The surgical injury of the intracranial portion of the facial nerve (FN) is a severe complication of many skull base procedures, and it represents a relevant issue in terms... 相似文献
94.
Marco Brenneis Sebastian Braun Stefan van Drongelen Benjamin Fey Timur Tarhan Felix Stief Andrea Meurer 《The Journal of arthroplasty》2021,36(3):1149-1155
BackgroundAccurate preoperative planning is a key component of successful total hip arthroplasty (THA). The purpose of the present study was to compare the accuracy and reliability of three-dimensional (hipEOS) and common digital two-dimensional (TraumaCad) templating with special focus on stem morphology.Methods51 patients undergoing THA were randomized to two groups. Preoperative planning was performed on 23 patients with hipEOS (3D) and on 28 patients with TraumaCad (2D) planning software. Planning results were compared with the implanted component size. Inter- and intraobserver reliability as well as planning accuracy of both planning methods with special focus on straight and short stem design were recorded.ResultsIntraobserver reliability of both planning methods was good for component planning (ICC2,1: 0.835-0.967). Interobserver ICC2,1 for stem and cup planning were higher for 3D templating (3D ICC2,1: 0.906-0.918 vs. 2D ICC2,1: 0.835-0.843). Total stem and cup size predictions were within 2 sizes for 3D and within 3 sizes for 2D planning. Comparing short stem planning accuracy of both planning methods, absolute difference between implanted and planned component size was significantly lower in 3D planning (P = .029). There was no significant difference in straight stem (P = .935) and cup (P = .954) planning accuracy.ConclusionOur findings suggest that 3D templating with hipEOS software has a good overall reliability and may have a better planning accuracy of short stem prostheses than digital templating with TraumaCad software. Assuming that the number of implanted short stem prostheses will further increase in coming years, a more precise planning with 3D technique can contribute to improve surgery outcome. 相似文献
95.
96.
Gustavo Martinez-Mier Pedro I. Moreno-Ley Luis F. Budar-Fernández Marco T. Méndez-López Carlos A. Allende-Castellanos Luis A. Jiménez-López Daniel A. Barrera-Amoros Edgar Aguilar-Sandoval Maritza De la Paz-Román Ernesto Soto-Miranda Yamilli Rivera-Sanchez Mónica Martínez-Maldonado 《Transplantation proceedings》2021,53(3):1005-1009
ContextThymoglobulin is used effectively as induction agent in kidney transplantation but the optimal dose is not well established.ObjectiveDemonstrate that low-dose thymoglobulin (3 mg/kg) has similar efficacy and safety compared to basiliximab induction in low-risk kidney transplantation under standard maintenance immunosuppressionDesign, Setting, ParticipantsProspective randomized study in kidney transplant patients (12/2016-05/2018). Inclusion criteria: Recipients > 18 years, first living donor transplant. Exclusion criteria: Second and multiorgan transplant, ABO incompatibility, positive cross-match, panel reactive antibodies (PRA) > 30%, positive donor-specific antibody, human immunodeficiency virus, hepatitis B surface antigen, hepatitis C virus positive, white blood cells < 2000 cells/mm3, platelets < 75,000 cells/mm3 and malignancy.InterventionGroup A: basiliximab (20 mg D0 and D4). Group B: thymoglobulin (3 mg/kg total). Maintenance immunosuppression: tacrolimus, mycophenolate mofetil, and steroids.Main Outcome MeasuresBiopsy-proven acute rejection (BPAR), delayed graft function, slow graft function, leukopenia, infections, adverse events, graft loss, estimated glomerular filtration rate, and death within 12 months.Results100 patients (basiliximab, n = 53) (thymoglobulin, n = 47) were included. Donor and recipient characteristics were similar except for longer dialysis (basiliximab), PRA class I (1.2% basiliximab, 4.5% thymoglobulin), HLA match (basiliximab 2.8, thymoglobulin 2.2), and cytomegalovirus status. BPAR rate was basiliximab 3.8% and thymoglobulin 6.4% (P = ns). Delayed graft function (basiliximab 3.8%; thymoglobulin 4.3%), slow graft function, and 12-month leukopenia (basiliximab 11.3%, thymoglobulin 21.3%) were similar between groups (P = ns). There was no difference in infections and adverse events between groups. Patient and graft survival were as follows: basiliximab 98.1% and 92.5%, thymoglobulin 100% and 93.6% (P = ns).ConclusionLow-dose thymoglobulin induction (3 mg/kg) can be used effectively and safely in low-risk kidney transplantation with good results during the first year post-transplant. 相似文献
97.
98.
99.
Virginia Masoni Leda Staletti Marco Berlusconi Alessandro Castagna Emanuela Morenghi 《Clinics in Orthopedic Surgery》2021,13(1):10
BackgroudCurrent evidence supports the use of cemented hemiarthroplasty for treatment of intracapsular femoral neck fractures since it is associated with a lower risk of implant-related complications. However, many medical centers employ the cementless technique for the frail elderly population because it is faster and has lower cardiovascular risks and perioperative mortality. This observational study reports the outcomes of cementless bipolar hemiarthroplasty for intracapsular femoral neck fractures in patients aged 80 years and older.MethodsA total of 424 patients (female, 77.1%) with a mean age of 86.9 years were operated for intracapsular femoral neck fractures between January 2009 and December 2017. Of those, 66.7% had an American Society of Anaesthesiologists (ASA) score of 3 or more. All operations were performed with the posterolateral surgical approach and all patients received a cementless stem. Intraoperative and perioperative values and in-hospital outcomes were evaluated, and clinical and radiographical follow-up was done at 40 days, 90 days, and when possible between 5 months and 12 months postoperatively. Multivariate analysis was performed to evaluate if there were factors affecting mortality.ResultsThe mean operative time was 50 minutes. There were no deaths intraoperatively. Intraoperative periprosthetic fractures occurred in 2.1% of the cases with 66.7% of them fixed through cerclage wires intraoperatively. The median length of hospitalization was 11 days (interquartile range, 8.75–15) and 2.4% of patients died while in hospital after surgery. Approximately 91.5% of patients presented with perioperative anemia. Only 1.9% of the complications were related to the implant, 62.5% of which were dislocations. More than 90% of patients were ambulatory either autonomously or with support at each follow-up assessment. Age, male sex, and higher ASA score were related to increased mortality.ConclusionsDespite some limitations, this observational study underlines that a cementless femoral stem of modern design can give good clinical outcomes, thus being an appropriate solution especially for the frail elderly. 相似文献
100.
Chan Stephen W. W. Chien C. W. Wong Arnold Y. L. Pang Marco Y. C. 《Quality of life research》2021,30(6):1779-1791
Quality of Life Research - To translate and cross-cultural validate the PROMIS Pediatric-25 Profile 2.0 (PROMIS-25) into traditional Chinese, and to investigate its psychometric properties in... 相似文献